Fleury (BSP:FLRY3) Other Current Assets: R$343 Mil (As of Mar. 2026)


BSP:FLRY3 Fleury SA BSP:FLRY3
91 GF Score
Price R$15.41
GF Value R$17.46
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Fleury Other Current Assets?

Fleury BSP:FLRY3 -1.03% 91 Other Current Assets is R$343 Mil as of Mar. 2026. GuruFocus rates BSP:FLRY3 with a GF Score™ of 91/100 and a GF Value™ of R$17.46 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Fleury's other current assets for the quarter that ended in Mar. 2026 was R$343 Mil.

Fleury's quarterly other current assets increased from Sep. 2025 (R$285 Mil) to Dec. 2025 (R$331 Mil) and increased from Dec. 2025 (R$331 Mil) to Mar. 2026 (R$343Mil).

Fleury's annual other current assets increased from Dec. 2023 (R$239 Mil) to Dec. 2024 (R$244 Mil) increased from Dec. 2024 (R$244 Mil) to Dec. 2025 (R$331 Mil).


Fleury Other Current Assets Related Terms


Fleury Other Current Assets Historical Data

* Premium members only.

The historical data trend for Fleury's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fleury Other Current Assets Chart

Fleury Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.92 128.49 239.30 244.11 331.21

Fleury Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 258.05 274.28 285.31 331.21 343.45
BSP:FLRY3
91GF Score
Fleury SA BSP:FLRY3
Other Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fleury Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.

Frequently Asked Questions Learn more about Other Current Assets →
What does a Other Current Assets of R$343 Mil mean?
Fleury (BSP:FLRY3) has a Other Current Assets of R$343 Mil as of Mar. 2026. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Fleury.
Is Fleury's Other Current Assets too high?
Fleury's current Other Current Assets is R$343 Mil. Overall, Fleury has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fleury's Other Current Assets compare to TMO and DHR?
Fleury's Other Current Assets of R$343 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Assets for a Medical Diagnostics & Research company?
A good Other Current Assets depends on the Medical Diagnostics & Research industry context. However, Other Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Assets mean?
A high Other Current Assets can signal that a stock is expensive relative to its fundamentals. Other current assets as record on a company's balance sheet not categorized as standard assets. View historical data on Fleury. Fleury's current Other Current Assets is R$343 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fleury stock overvalued right now?
Based on GuruFocus' analysis, Fleury (BSP:FLRY3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$17.46, compared to a current price of R$15.41 — trading 11.7% below its estimated fair value. The current Other Current Assets is R$343 Mil. Fleury's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Assets calculated?
Other Current Assets is calculated from a company's financial statements. For Fleury (BSP:FLRY3), the current Other Current Assets is R$343 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fleury (BSP:FLRY3) Overvalued in 2026?

Based on GuruFocus' analysis, Fleury stock appears to be undervalued. The current stock price of R$15.41 is trading 11.7% below its estimated GF Value™ of R$17.46. GuruFocus considers Fleury to be Modestly Undervalued.

Key valuation signals for BSP:FLRY3:

  • Other Current Assets: R$343 Mil
  • GF Value™: R$17.46 vs. price of R$15.41 (11.7% below fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the BSP:FLRY3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fleury Business Description

Address Avenida Morumbi 8.860, 8th floor, Brooklin, Sao Paulo, SP, BRA, 04703-002
Fleury SA is engaged in the provision of medical services in the diagnostic, laboratory support (Lab-to-Lab), infusions, clinical analysis, health management, medical care, orthopedics and ophthalmology, fertility, infusion areas and toxicological exams, among others. The company offers diagnostic medicine through physical service units and mobile diagnostic services for consumers. It also provides diagnostic support services to laboratories and hospitals. In addition, the company operates clinics and services in areas such as infusion therapy, orthopedics, ophthalmology, reproductive medicine, and oncology. It has two reportable business segments: Diagnostic Medicine and Integrated Medicine. The maximum revenue is generated from the Diagnostic Medicine Segment.
91GF Score

Get the complete analysis for BSP:FLRY3

Other Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$15.41
Price
R$17.46
GF Value